BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1308169)

  • 1. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB; Morgan GJ; Wiedemann LM
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of chronic myeloid leukemia.
    Maru Y
    Int J Hematol; 2001 Apr; 73(3):308-22. PubMed ID: 11345196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The function of BCR/ABL and related proto-oncogenes.
    Gotoh A; Broxmeyer HE
    Curr Opin Hematol; 1997 Jan; 4(1):3-11. PubMed ID: 9050373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights into the Philadelphia translocation.
    Heisterkamp N; Groffen J
    Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Philadelphia chromosome: from the gene to therapeutic methods].
    Pérez-Losada J; González-Sarmiento R; Sánchez-García I
    Sangre (Barc); 1998 Apr; 43(2):127-35. PubMed ID: 9656774
    [No Abstract]   [Full Text] [Related]  

  • 6. The bcr-abl gene in chronic myelogenous leukaemia.
    Sawyers CL
    Cancer Surv; 1992; 15():37-51. PubMed ID: 1451113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.
    He Y; Wertheim JA; Xu L; Miller JP; Karnell FG; Choi JK; Ren R; Pear WS
    Blood; 2002 Apr; 99(8):2957-68. PubMed ID: 11929787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia.
    Inokuchi K; Shinohara T; Futaki M; Hanawa H; Tanosaki S; Yamaguchi H; Nomura T; Dan K
    Genes Chromosomes Cancer; 1998 Nov; 23(3):227-38. PubMed ID: 9790503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcr: a negative regulator of the Bcr-Abl oncoprotein.
    Wu Y; Ma G; Lu D; Lin F; Xu HJ; Liu J; Arlinghaus RB
    Oncogene; 1999 Aug; 18(31):4416-24. PubMed ID: 10442632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
    Muller AJ; Young JC; Pendergast AM; Pondel M; Landau NR; Littman DR; Witte ON
    Mol Cell Biol; 1991 Apr; 11(4):1785-92. PubMed ID: 2005881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of Bcr in leukemias with the Philadelphia chromosome.
    Arlinghaus RB
    Crit Rev Oncog; 1998; 9(1):1-18. PubMed ID: 9754444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia.
    Diamond J; Goldman JM; Melo JV
    Blood; 1995 Apr; 85(8):2171-5. PubMed ID: 7718887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
    Rosson D; Reddy EP
    Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation.
    Chissoe SL; Bodenteich A; Wang YF; Wang YP; Burian D; Clifton SW; Crabtree J; Freeman A; Iyer K; Jian L
    Genomics; 1995 May; 27(1):67-82. PubMed ID: 7665185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Abl in oxidative stress, aging and cancer.
    Li B
    Cell Cycle; 2005 Feb; 4(2):246-8. PubMed ID: 15655364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia.
    Melo JV; Gordon DE; Tuszynski A; Dhut S; Young BD; Goldman JM
    Blood; 1993 May; 81(10):2488-91. PubMed ID: 8490164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.
    Arlinghaus RB
    Oncogene; 2002 Dec; 21(56):8560-7. PubMed ID: 12476302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice.
    Heisterkamp N; Voncken JW; Senadheera D; Hemmeryckx B; Gonzalez-Gomez I; Reichert A; Pattengale PK; Groffen J
    Int J Mol Med; 2001 Apr; 7(4):351-7. PubMed ID: 11254872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
    Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
    Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
    Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON
    Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.